Scrip
Cephalon feels the pain as forecasts drop
28 October 2009
Simon Varcoe
Please Login to read the full article.
28 October 2009
Simon Varcoe
simon.varcoe@informa.com
Cephalon has lowered its full-year sales guidance despite its third-quarter revenues increasing by 9% to $535 million.
The company's central nervous system (CNS) and oncology franchises performed particularly well, increasing in sales by 7% to $292 million and 58% to $83 million respectively....
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Face-to-Face: Trophos - The French firm that hooked Actelion
- Connexios: Harnessing the Indian cost advantage in network biology
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
